UNHUnitedhealth Group Inc
Slide 1 of 3
Company Overview
Name
Unitedhealth Group Inc
52W High
$609.61
52W Low
$233.13
Market Cap
$280B
Dividend Yield
2.789%
Price/earnings
2.59
P/E
2.59
Tags
Dividends
Dividends Upcoming
Own this stock by Dec 8, 2025
Dec 16, 2025
$2.21 per share
Sentiment
Score
Mixed
50
Low
Neutral
High
0
50
100
Trade Volume
Score
Neutral
50
Low
Neutral
High
0
50
100
Slide 2 of 3
Income Statement
Total Revenue
$113.2B
Operating Revenue
$113.2B
Total Gross Profit
$20.6B
Total Operating Income
$4.3B
Net Income
$2.5B
EV to EBITDA
$9.39
EV to Revenue
$0.66
Price to Book value
$2.92
Price to Earnings
$15.92
Additional Data
Selling, General & Admin Expense
$15.2B
Depreciation Expense
$1.1B
Total Operating Expenses
$-16.3B
Interest Expense
$-1B
Other Income / (Expense), net
$-83M
Total Other Income / (Expense), net
$-1.1B
Slide 3 of 3
Earnings History
Estimated EPS
Reported EPS
N/A Slide 1 of 5
Company Overview
Name
Unitedhealth Group Inc
52W High
$609.61
52W Low
$233.13
Market Cap
$280B
Dividend Yield
2.789%
Price/earnings
2.59
P/E
2.59
Tags
Dividends
Dividends Upcoming
Own this stock by Dec 8, 2025
Dec 16, 2025
$2.21 per share
Slide 2 of 5
Sentiment
Score
Mixed
50
Low
Neutral
High
0
50
100
Trade Volume
Score
Neutral
50
Low
Neutral
High
0
50
100
Slide 3 of 5
Income Statement
Total Revenue
$113.2B
Operating Revenue
$113.2B
Total Gross Profit
$20.6B
Total Operating Income
$4.3B
Net Income
$2.5B
EV to EBITDA
$9.39
EV to Revenue
$0.66
Price to Book value
$2.92
Price to Earnings
$15.92
Slide 4 of 5
Additional Data
Selling, General & Admin Expense
$15.2B
Depreciation Expense
$1.1B
Total Operating Expenses
$-16.3B
Interest Expense
$-1B
Other Income / (Expense), net
$-83M
Total Other Income / (Expense), net
$-1.1B
Slide 5 of 5
Earnings History
Estimated EPS
Reported EPS
N/AUpcoming Earnings
We were not able to find an announced earnings date for this symbol yet. Check back again later
Company Info
CEO
Sir Andrew Philip Witty
Location
Minnesota, USA
Exchange
NYSE
Website
https://unitedhealthgroup.com
Summary
UnitedHealth Group Incorporated operates as a diversified health care company in the United States.
Company Info
CEO
Sir Andrew Philip Witty
Location
Minnesota, USA
Exchange
NYSE
Website
https://unitedhealthgroup.com
Summary
UnitedHealth Group Incorporated operates as a diversified health care company in the United States.
Company FAQ
@autobot 7 months ago | 2025 - q1
What does this company do? What do they sell? Who are their customers?
UnitedHealth Group Incorporated is a prominent diversified health care company operating primarily in the United States. The organization is structured into segments, with UnitedHealthcare providing a spectrum of consumer-oriented health benefit plans. These services cater to various clients, including national and public sector employers, mid-sized companies, small businesses, and individual consumers. Alongside UnitedHealthcare, the company operates OptumRx, which delivers pharmacy care services and innovative programs, integrating retail network contracting and home delivery solutions. A leader in its field, UnitedHealth Group leverages its vast resources to serve millions, focusing on improving health care quality while controlling costs.
What are the company’s main products or services?
UnitedHealthcare's primary service offerings include comprehensive health benefit plans tailored for diverse audiences, from large national employers to individuals, ensuring a wide coverage scope.,The OptumRx segment specializes in offering pharmacy care services, including retail network contracting, specialty pharmacy solutions, and clinical management programs.,Beyond insurance, UnitedHealth provides value-based care models, leveraging technology and innovations to enhance health care delivery and operations.,OptumHealth and Optum Insights are pivotal segments that contribute to the company's portfolio, focusing on health care delivery and analytical insights, respectively.,UnitedHealth also offers Medicare Advantage plans, showcasing flexibility and improved payment terms in alignment with governmental policy changes.
Who are the company’s main competitors?
Humana, a significant player also offering Medicare services and health insurance solutions, stands as one of UnitedHealth's primary competitors.,CVS Health, which owns Aetna, competes with UnitedHealth in health insurance and pharmacy services.,Anthem, another major health insurance provider, frequently competes in similar markets, particularly around employer-based health benefit plans.
What drives the company’s stock price?
UnitedHealth Group's stock price is heavily influenced by factors such as its strong earnings performance and the broader market trends affecting the health care industry. Recent announcements regarding Medicare Advantage payment rate increases have positively impacted the stock prices of several health insurers, including UnitedHealth. Additionally, the company’s consistent dividend payments and historical growth in revenue and net income can act as drivers. Overall market sentiment and economic conditions, such as policy changes in health care, also play critical roles in influencing stock price movements.
What were the major events that happened this quarter?
In the most recent quarter, UnitedHealth Group experienced a substantial 9% increase in revenue, reaching $101 billion, driven by growth in their OptumHealth and OptumRx segments. The company successfully added over 2.4 million members to its domestic commercial business. They faced challenges due to Medicare budget cuts and a cyberattack impacting Change Healthcare, which influenced their earnings for the year 2024. Despite these hurdles, UnitedHealth maintained resilience, continuing to pursue growth through strategic plans and investments in value-based care and artificial intelligence.
What do you think will happen next quarter?
For the upcoming quarter, UnitedHealth Group anticipates an increase in earnings per share, forecasting $7.27, indicating a 5.21% rise. Revenue is also expected to grow to about $111.01 billion, marking an 11.24% increment. The outlook remains optimistic due to ongoing expansions in market segments like Medicare Advantage. Investors should also watch for potential impacts from policy changes and innovation strategies like continued integration of AI technologies. Economic conditions at large and policy adjustments may also influence both revenue prospects and market positioning.
What are the company’s strengths?
UnitedHealth Group's primary strengths include a strong market reputation as a leader in health insurance services, coupled with a diverse portfolio of health care products. Its dual-segment model enables effective risk management and revenue diversification. The company's financial health reflects solid earnings, a commendable Return on Equity exceeding industry averages, and consistent dividend payments that attract long-term investors. UnitedHealth’s dedication to technological advancements and innovations, particularly in pharmacy operations, further solidifies its market position.
What are the company’s weaknesses?
Some vulnerabilities for UnitedHealth Group include their exposure to regulatory challenges and scrutiny, particularly regarding Medicare Advantage profitability and coding practices. High dividend payouts have been speculated to potentially limit the growth of net income, indicating room for improvement in capital reinvestment strategies. The company's stock performance can also be susceptible to fluctuating market conditions and broader economic trends. Competitor strategies and pricing models present ongoing challenges in maintaining market share and competitive advantage.
What opportunities could the company capitalize on?
UnitedHealth Group has significant growth opportunities in expanding its Medicare Advantage plans, especially following positive adjustments in government payment rates. Innovation in technology, especially in AI, presents avenues for enhancing operational efficiency and customer service offerings in pharmacy care. Moreover, the company can explore international markets or demographics, offering personalized or tailored health care solutions. Collaborations or partnerships within industry segments further augment the potential for sustainable growth and diversification.
What risks could impact the company?
UnitedHealth Group faces various risks, including ongoing governmental and regulatory pressure, which can affect revenue streams like Medicare jobs. Market concentration and scrutiny over aggressive coding practices pose reputational challenges. Additionally, external threats such as cyberattacks continue to pose risks to operational stability, as seen with the Change Healthcare incident. Economic fluctuations, unexpected health policy changes, and heightened competition from peers like Humana and CVS can further influence company performance.
What’s the latest news about the company?
UnitedHealth Group has been highlighted in various news articles for its strong financial performance and strategic position among health insurers. Noteworthy events include its stock price slightly outperforming a declining S&P 500, revenues climbing to impressive figures in recent periods, and strategic positioning in Medicaid and Medicare sectors. However, challenges such as scrutiny following organizational changes and industry pressures remain. Analysts continue to recognize UnitedHealth for its dividend-paying history and potential investment value amidst fluctuating market conditions.
What market trends are affecting the company?
Broader market trends impacting UnitedHealth Group include evolving health care policies like Medicare Advantage payment adjustments and pharma-sector innovations. A general shift towards value-based care models and AI integration speaks to the larger digital transformation in health care. Notably, the American health care landscape is under scrutiny due to increased calls for regulations, which could alter insurer strategies and reimbursement practices. The rise of contrarian investment strategies and portfolio diversification by major market players underscores trends towards stability and long-term value.
Price change
$602.00
